RIVAS MARIO (Chief Executive Officer) received a stock award from TRANSPHORM, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/12/2020ACC: 0001209191-20-018554
DirectorOfficer· Chief Executive Officer
Since Feb 2020
+12.50K
Net shares
Net buyer
$50.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$4.00
Trade value
$50K
% of position
New position
2/12/2020
0.00→12.50K
Total
Net shares
+12.50K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2020 | A · Award | +12.50K | $4.00 | $50K | New position | 0.00 | 12.50K |
| Total | +12.50K | $50K | ||||||
Derivative Transactions0
No derivative transactions reported